Núñez-Toldrà Raquel, Martínez-Sarrà Ester, Gil-Recio Carlos, Carrasco Miguel Ángel, Al Madhoun Ashraf, Montori Sheyla, Atari Maher
Regenerative Medicine Research Institute, Universitat Internacional de Catalunya, Barcelona, Spain.
Chair of Regenerative Implantology MIS-UIC, Barcelona, Spain.
BMC Cell Biol. 2017 Apr 21;18(1):21. doi: 10.1186/s12860-017-0137-9.
Biomaterials are widely used to regenerate or substitute bone tissue. In order to evaluate their potential use for clinical applications, these need to be tested and evaluated in vitro with cell culture models. Frequently, immortalized osteoblastic cell lines are used in these studies. However, their uncontrolled proliferation rate, phenotypic changes or aberrations in mitotic processes limits their use in long-term investigations. Recently, we described a new pluripotent-like subpopulation of dental pulp stem cells derived from the third molars (DPPSC) that shows genetic stability and shares some pluripotent characteristics with embryonic stem cells. In this study we aim to describe the use of DPPSC to test biomaterials, since we believe that the biomaterial cues will be more critical in order to enhance the differentiation of pluripotent stem cells.
The capacity of DPPSC to differentiate into osteogenic lineage was compared with human sarcoma osteogenic cell line (SAOS-2). Collagen and titanium were used to assess the cell behavior in commonly used biomaterials. The analyses were performed by flow cytometry, alkaline phosphatase and mineralization stains, RT-PCR, immunohistochemistry, scanning electron microscopy, Western blot and enzymatic activity. Moreover, the genetic stability was evaluated and compared before and after differentiation by short-comparative genomic hybridization (sCGH).
DPPSC showed excellent differentiation into osteogenic lineages expressing bone-related markers similar to SAOS-2. When cells were cultured on biomaterials, DPPSC showed higher initial adhesion levels. Nevertheless, their osteogenic differentiation showed similar trend among both cell types. Interestingly, only DPPSC maintained a normal chromosomal dosage before and after differentiation on 2D monolayer and on biomaterials.
Taken together, these results promote the use of DPPSC as a new pluripotent-like cell model to evaluate the biocompatibility and the differentiation capacity of biomaterials used in bone regeneration.
生物材料被广泛用于骨组织的再生或替代。为了评估其临床应用潜力,需要使用细胞培养模型在体外对其进行测试和评估。在这些研究中,常使用永生化成骨细胞系。然而,其不受控制的增殖速率、表型变化或有丝分裂过程中的异常限制了它们在长期研究中的应用。最近,我们描述了一种源自第三磨牙的牙髓干细胞新的多能样亚群(DPPSC),其具有遗传稳定性,并与胚胎干细胞共享一些多能特性。在本研究中,我们旨在描述DPPSC在测试生物材料中的应用,因为我们认为生物材料线索对于增强多能干细胞的分化更为关键。
将DPPSC分化为成骨谱系的能力与人类肉瘤成骨细胞系(SAOS-2)进行比较。使用胶原蛋白和钛来评估常用生物材料中的细胞行为。通过流式细胞术、碱性磷酸酶和矿化染色、RT-PCR、免疫组织化学、扫描电子显微镜、蛋白质免疫印迹和酶活性进行分析。此外,通过短串联比较基因组杂交(sCGH)评估和比较分化前后的遗传稳定性。
DPPSC在表达与SAOS-2相似的骨相关标志物方面表现出向成骨谱系的优异分化。当细胞在生物材料上培养时,DPPSC表现出更高的初始黏附水平。然而,两种细胞类型的成骨分化都呈现出相似的趋势。有趣的是,只有DPPSC在二维单层和生物材料上分化前后都保持正常的染色体剂量。
综上所述,这些结果促进了将DPPSC用作一种新的多能样细胞模型,以评估用于骨再生的生物材料的生物相容性和分化能力。